Facebook-f Twitter Tiktok Instagram Youtube
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
ATRA — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

9.63

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

-3.49

EPS This/Next Y

2.15

Price

8.47

Target Price

13.67

Analyst Recom

1.67

Performance Q

-14.9

Upside

-464.5%

Beta

0.1

Ticker: ATRA



20 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-07-13ATRA8.67N/AN/A0
2026-07-14ATRA8.05N/AN/A0
2026-07-15ATRA8.59N/AN/A0
2026-07-16ATRA8.77N/AN/A0
2026-07-17ATRA8.33N/AN/A0
2026-07-20ATRA8.24N/AN/A0
2026-07-21ATRA8.64N/AN/A0
2026-07-22ATRA8.16N/AN/A0
2026-07-23ATRA8.32N/AN/A0
2026-07-24ATRA7.91N/AN/A0
2026-07-27ATRA7.69N/AN/A0
2026-07-28ATRA7.89N/AN/A0
2026-07-29ATRA8N/AN/A0
2026-07-30ATRA8.17N/AN/A0
2026-07-31ATRA8.39N/AN/A0
2026-08-03ATRA8.49N/AN/A0
2026-08-04ATRA8.84N/AN/A0
2026-08-05ATRA8.61N/AN/A0
2026-08-06ATRA8.27N/AN/A0
2026-08-07ATRA8.58N/AN/A0
DateSymbolLatestP/C OIP/C VolTotal OI
20 items Current Page1 of 1



20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-07-13ATRA8.77-100.0- -0.88
2026-07-14ATRA8.15-100.0- -0.88
2026-07-15ATRA8.55-100.0- -0.88
2026-07-16ATRA8.79-100.0- -0.88
2026-07-17ATRA8.58-100.0- -0.88
2026-07-20ATRA8.23-100.0- -0.88
2026-07-21ATRA8.58-100.0- -0.88
2026-07-22ATRA8.12-100.0- -0.88
2026-07-23ATRA8.24-100.0- -0.88
2026-07-24ATRA7.91-100.0- -0.88
2026-07-27ATRA7.78-100.0- -0.88
2026-07-28ATRA7.75-100.0- -0.88
2026-07-29ATRA8.06-100.0- -0.88
2026-07-30ATRA8.22-100.0- -0.88
2026-07-31ATRA8.47-100.0- -0.88
2026-08-03ATRA8.49-100.0- -0.88
2026-08-04ATRA8.49-100.0- -0.88
2026-08-05ATRA8.61-100.0- -0.88
2026-08-06ATRA8.32-100.0- -0.88
2026-08-07ATRA8.47-100.0- -0.88
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1



20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-07-13ATRA3.461.036.03
2026-07-14ATRA3.461.036.03
2026-07-15ATRA6.411.036.03
2026-07-16ATRA6.411.036.03
2026-07-17ATRA6.411.036.03
2026-07-20ATRA6.411.036.03
2026-07-21ATRA6.411.036.03
2026-07-22ATRA6.411.036.03
2026-07-23ATRA6.411.036.03
2026-07-24ATRA6.411.036.03
2026-07-27ATRA6.411.039.63
2026-07-28ATRA6.411.039.63
2026-07-29ATRA6.411.039.63
2026-07-30ATRA6.411.039.63
2026-07-31ATRA6.411.039.63
2026-08-03ATRA6.411.049.63
2026-08-04ATRA6.411.049.63
2026-08-05ATRA6.411.049.63
2026-08-06ATRA6.411.049.63
2026-08-07ATRA6.411.049.63
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

-0.25

Avg. EPS Est. Next Quarter

-0.2

Insider Transactions

6.41

Institutional Transactions

1.04

Beta

0.1

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

68

Growth Score

42

Sentiment Score

75

Actual DrawDown %

98.3

Max Drawdown 5-Year %

-99.2

Target Price

13.67

P/E

Forward P/E

9.44

PEG

P/S

3.29

P/B

P/Free Cash Flow

EPS

-0.88

Average EPS Est. Cur. Y​

-0.88

EPS Next Y. (Est.)

1.27

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-40.91

Relative Volume

0.02

Return on Equity vs Sector %

-2

Return on Equity vs Industry %

14.1

EPS 1 7Days Diff

0.4

EPS 1 30Days Diff

0.35

EBIT Estimation

◆ ATRA Healthcare
$8.45
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
18/20
Pullback
15/25
Volume
11/15
Valuation
15/20
TP/AR
3/10
Options
0/10
RSI
46.2
Range 1M
33.5%
Sup Dist
5.2%
🚀
Momentum Growth
Ride accelerating trends
N/A
26 /100
WEAK
Momentum
5/25
Growth
10/30
Estimates
8/20
Inst/Vol
3/15
Options
0/10
EPS Yr
-150.4%
EPS NY
169.1%
52W%
29.4%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +321.9% upside
Quality
6/30
Valuation
18/30
Growth
8/25
Stability
7/10
LT Trend
3/5
Upside
+321.9%
Quality
68
Click a card to see score breakdown Full Analysis →
ATRA — P/E HistoricalBiotechnology
Atara Biotherapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 13
Atara Biotherapeutics, Inc. engages in the development of transformative therapies for patients with cancer and autoimmune disease in the United States and internationally. Its lead product includes Tab-cel (tabelecleucel), a T-cell immunotherapy program that is in Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) with post-transplant lymphoproliferative disease, as well as other EBV-driven diseases. It also develops ATA3219, an allogeneic CAR T targeting CD19 intended to target B-cell malignancies and autoimmune diseases. The company has research collaboration agreements with Memorial Sloan Kettering Cancer Center, and Council of the Queensland Institute of Medical Research. Atara Biotherapeutics, Inc. was incorporated in 2012 and is headquartered in Thousand Oaks, California.
ATRA

Latest News

—
Caricamento notizie per ATRA…
stock quote shares ATRA – Atara Biotherapeutics, Inc. Stock Price stock today
news today ATRA – Atara Biotherapeutics, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch ATRA – Atara Biotherapeutics, Inc. yahoo finance google finance
stock history ATRA – Atara Biotherapeutics, Inc. invest stock market
stock prices ATRA premarket after hours
ticker ATRA fair value insiders trading